D-mannose inhibits triple-negative breast cancer via specific molecular axis
A new study reveals that D-mannose suppresses triple-negative breast cancer progression by modulating the miR-2116-3p/BAP1/KLF5 molecular axis.
A new study reveals that D-mannose suppresses triple-negative breast cancer progression by modulating the miR-2116-3p/BAP1/KLF5 molecular axis.
An exploratory study of 33 patients found that handheld multispectral optoacoustic tomography detected significantly higher hemoglobin-related and wavelength-specific signals in ...
An analysis of 172,512 German breast cancer cases shows that molecular subtypes are associated with both the timing and organ ...
An analysis of 5,318 early breast cancer patients found that 2 percent developed brain metastases at first recurrence, with triple-negative ...
Triple-negative breast cancer represents a particularly aggressive subtype of the disease, characterized by the absence of hormone receptors and HER2 ...
A self-assembling nanomedicine combining orlistat and chlorin e6 rewires fat metabolism in triple-negative breast cancer to amplify ferroptosis, boost photodynamic ...
New research from Türkiye finds that triple-negative breast cancers can present with deceptively benign-looking ultrasound features, challenging conventional radiological assumptions ...
CA 15-3 is an epitope of the MUC1 glycoprotein. MUC1 is a transmembrane mucosa-associated glycoprotein and contains a large extracellular ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.